Grants for Adapting Cancer Biomarkers for Clinical Validation Projects in New York (USA)
GrantID: 68668
Grant Funding Amount Low: $150,000
Deadline: October 14, 2026
Grant Amount High: $150,000
Summary
This grant focuses on the crucial adaptation and clinical validation of innovative molecular, cellular, and imaging markers aimed at enhancing cancer detection and treatment. It supports projects that assess the effectiveness of biomarkers in predicting treatment responses and monitoring disease progression. It seeks to bridge the gap between research and clinical practice, ensuring that validated biomarkers play a vital role in oncology. The validation of cancer care can be revolutionized for enhanced patient support...
Eligible Regions
Interests
Eligible Requirements
Grant Detailed Description
View Full Grant Details
Additional Criteria of Eligibility
Additional Funding in Information
Estimated Size of Grant
Contact Info
Funding Source
Overview
This grant is meant to financially support organizations or entities that focus their efforts on, but not limited to: Awards, Business & Commerce, Education, Financial Assistance, Health & Medical, Higher Education, Municipalities, Non-Profit Support Services, Other, Science, Technology Research & Development, Small Business in New York (USA).